Lidocaine CRI for Mules: Uses for Ileus, Pain & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Lidocaine CRI means lidocaine given by continuous intravenous infusion through a catheter and fluid pump in a hospital setting. Lidocaine is best known as a local anesthetic, but in equids it is also used systemically as an adjunct medication for some cases of ileus, abdominal pain, and ventricular arrhythmias. In horses, published references describe it as an amide local anesthetic and class IB antiarrhythmic, with equine CRI protocols commonly adapted by your vet for closely related species such as mules.

For mules, your vet will usually base treatment on equine data plus the individual mule's response, because mule-specific pharmacology studies are limited. That matters because mules can differ from horses in drug handling and behavior, so careful monitoring is more important than copying a horse protocol at home.

This is not a take-home medication. Lidocaine CRI is typically used in referral hospitals or well-equipped field settings where your vet can monitor heart rate, rhythm, mentation, gut sounds, manure output, and signs of toxicity while adjusting the infusion.

In mules, lidocaine CRI is most often discussed for ileus, especially when the intestines are moving poorly after abdominal surgery, severe colic, inflammation, or prolonged gut distension. In equine medicine, lidocaine has long been used as a commonly administered prokinetic drug for postoperative ileus, although the evidence is mixed and not every case responds the same way. Your vet may use it as one part of a broader plan that also includes decompression, fluids, electrolyte support, pain control, and treatment of the underlying intestinal problem.

It may also be used as an adjunct for pain management, especially when your vet wants to reduce reliance on other drugs or build a multimodal analgesia plan. The pain benefit appears to be more consistent for some perioperative and inflammatory situations than for every type of visceral colic pain, so your vet will match the plan to the clinical picture.

Less commonly, lidocaine CRI may be used for certain ventricular arrhythmias in equids. That use requires ECG and cardiovascular monitoring because the same drug that can help stabilize abnormal rhythms can also cause adverse neurologic or cardiovascular effects if the dose is too high or the patient clears the drug poorly.

Lidocaine CRI dosing in mules should be determined only by your vet. Mule-specific published dosing is limited, so most clinicians start from equine references and then adjust based on the mule's weight, hydration, cardiovascular status, liver perfusion, concurrent drugs, and response to treatment.

In horses, commonly cited hospital protocols for ileus or perioperative infusion use a loading dose around 1.3 mg/kg IV, followed by a CRI around 0.05 mg/kg/min. Merck also lists equine IV CRI ranges of roughly 20-50 mcg/kg/min for analgesic use and 0.05 mg/kg/min for ventricular tachycardia protocols. Some studies and reviews report slightly different infusion rates, which is one reason your vet may individualize the plan rather than follow a single fixed number.

Because lidocaine has a narrow margin between therapeutic and toxic effects in some patients, dosing is usually adjusted with continuous observation. Long infusions, reduced liver blood flow, anesthesia, shock, dehydration, or concurrent highly protein-bound drugs may increase the risk of accumulation. If a mule shows sedation, ataxia, tremors, or cardiovascular changes, your vet may slow or stop the infusion and reassess the whole treatment plan.

See your vet immediately if your mule develops marked weakness, stumbling, muscle tremors, collapse, seizures, or sudden worsening of heart rate or breathing during or after a lidocaine infusion. These can be signs of toxicity and need prompt veterinary attention.

In equids, the most commonly reported adverse effects of IV lidocaine are depression or dullness, ataxia, and muscle tremors. These signs often improve after the infusion is reduced or stopped, but they should never be ignored. At higher blood levels or with overdose, more serious effects such as hypotension, bradycardia, and seizures have been reported.

Some mules may also show less specific changes such as reduced appetite, agitation, or unusual behavior. Risk can be higher when the patient is critically ill, under anesthesia, has reduced liver perfusion, or is receiving other medications that affect protein binding or cardiovascular function. Because early toxicity can look subtle, hospital monitoring is a major part of safe use.

Lidocaine CRI can interact with other medications, so your vet should review every drug, supplement, and recent treatment your mule has received. This includes sedatives, anesthetic drugs, antiarrhythmics, pain medications, antibiotics, and electrolyte therapies.

A key practical concern in equids is that longer infusions may lead to higher lidocaine concentrations when used with highly protein-bound drugs such as flunixin or ceftiofur, according to equine review literature. Drugs that reduce liver blood flow or change cardiovascular stability may also affect how quickly lidocaine is cleared.

Because lidocaine itself can affect the nervous system and heart, combining it with other drugs that cause sedation, low blood pressure, rhythm changes, or neurologic excitation may increase monitoring needs. That does not mean these combinations can never be used. It means your vet should choose them deliberately, with dose adjustments and monitoring based on the mule's condition.